Fungal metabolites with an epz-oligothiadiketopiperazine structure, TAN-1496 A, C and E, were isolated from the culture broth of Microsphaeropsis sp. FL-16144. Their molecular formulas were determined to be C22H28N2O9S2,C22H28N2O9S3and C22H28N2O9S4,respectively. Structures were determined by comparing the NMRdata with those of known diketopiperazine antibiotics, sirodesmins. These metabolites inhibited the relaxation of supercoiled pBR322DNAby calf thymus topoisomerase I but did not affect the decatenation ofkinetoplast DNAby calf thymus topoisomerase II at concentration up to 500 /j.m. They strongly suppressed the growth of various murine and human tumor cells and induced apoptosis. Moreover, various derivatives were synthesized to investigate the relationship of their functional groups and biological activities.
The death rate due to malignant tumors has been steadily increasing, and in the area of cancer chemotherapy, we are in need of potent antitumor agents to inhibit the proliferation of such cancers. DNA topoisomerase I (Topo I), a nuclear enzyme responsible for DNAmetabolism1*, has been proposed as an intracellular target for cancer therapeutics2*. In fact, the alkaloid camptothecin (CPT) and several of its analogs specifically inhibit Topo I and show considerable efficacy against a broad spectrum of human tumor xenografts.3~5) In our search for TopoI inhibitors of microbial origin, five metabolites were found in the culture broth of a fungus strain isolated from a soil sample. Three of them, TAN-1496 A (1), C (3) and E (5), were proved to be new compounds having specific inhibitory activity against Topo I (Fig. 1) . The other two, TAN-1496 B (2) and D (4), were found to be identical to sirodesmin A and its deacetyl derivative, respectively. This paper describes taxonomic studies of the producing organism and fermentation, isolation, structure determination, biological activities and modification of the antibiotics. 
Results
Fermentation A spore suspension of Microsphaeropsis sp. FL-16144 was inoculated into a 2-liter Sakaguchi flask containing 500ml of a sterile seed medium consisting of glucose 2%, soluble starch 3%, soybean flour 1.5%, corn steep liquor 1%, Polypepton 0.5%, yeast extract 0.3%, NaCl 0.3% and CaCO3 0.5%. The flask was shaken on a reciprocal shaker at 24°C for 48 hours. One and a half liters of the seed culture was transferred to a 200-liter fermentor containing 120 liters of a production mediumconsisting of glucose 1%, dextrin 4%, soybean flour 0.5%, Polypepton 0.5%, meat extract 0.5%, FeSO4 0.05%, MnSO4 0.05%, MgSO4 0.05%, KH2PO40.1% and CaCO3 0.5%. Fermentation was carried out at 24°C with aeration at 120 liters/minute and agitation at 180 rpm. The production of the major metabolite, 1, reached a maximum (81 jug/ml) 1 14 hours after inoculation.
Taxonomy of the Producing Organism Culture characterization was carried out following the methods described by Malloch6) and Sutton7). Scanning electron microscopy was conducted by the method of Tanida et al.8\ Strain FL-16144 was isolated from a soil sample collected in Ibaragi prefecture, Japan. Macroscopic characteristics of strain FL-16144on malt extract agar were as follows: the colony is ventinous with a regular periphery; the aerial hyphae are grayish white and develop concentrically; the reverse side of the colony is yellowish brown at the center and pale yellow to pale yellowish brown at the periphery; no pigment production is observed.
Microscopic characteristics of the strain were as follows: the hyphae are 1~3 /on in diameter, hyaline to pale brown, immersed, branched and septate; the pycnidia are globose to irregular and immersed; peridia are thin-walled, hyaline to pale brown, somewhat gelatinous; the conidiogenous cell ampulliform is monophialidic; conidia are 4.0~4.5 x 2.2~2.8 /mi, subglobose to ellipsoid, aseptate, smooth and brown (plate 1). These characteristics indicate that strain FL-16144 belongs to the genus Microsphaeropsis. Therefore, the strain is designated Microsphaeropsis sp. FL-16144. Plate 1. Light and scanning electron micrographs of strain FL-16144.
The organism was cultured on malt extract agar for 2 weeks at 28°C. A, a pycnidium ( x400); B, spores ( x 5,000).
Isolation
The general procedure for the isolation of 1~5 is summarized in Fig. 2 . The antibiotics are neutral, fat-soluble compounds; therefore solvent extraction, silica gel chromatography and preparative reversed-phase HPLCare used for purification. Theamount of bioactive componentswasestimated by the inhibitory activity against Topo I or analyzed by HPLC: column, octadecylsilane (ODS), mobile phase, 45% acetonitrile/0.01 m phosphate buffer (pH 6.3). Chemical Characterization Compounds1~5 showed positive color reactions with iodine and potassium permanganate and are easily soluble in methanol, acetone, ethyl acetate, chloroform, etc. The IR spectra showed characteristic absorption in the carbonyl region. The molecular formula of 1 was determined from the elemental analysis, EI-MSand 13C NMR spectrum. Those of other components were determined in the same manner as listed in Table 1 . The 13C and 1H NMRspectra of 1~5 are listed in Tables 2 and 3 . Compounds 3 and 5 had additional one and two sulfur atoms in the molecule, respectively. In the EI-MS spectra the major peaks were detected as M+ -nS (n=2~4), while the molecular ion peaks (E+) were detected as the minor ones (1, 2 and 4) or not detected (3 and 5). On treatment of 1 with triphenylphosphine in dichloromethane or tetrahydrofuran (THF), the monosulfide derivative (6, see Fig. 6 ) was obtained without cleavage of the sulfide bond. These phenomena9) are characteristic features of e/?/-oligothiadiketopiperazine compounds such as gliotoxin10) and sporidesmins11*. Therefore, 1~5 are regarded as belonging to this family.
Structure Determination The NMRdata revealed that 2 and 4 had one or no acetyl groups in the molecules, respectively. Amongthe diketopiperazine antibiotics, sirodesmin A12) has almost the same partial structures, except for one acetyl group. Comparison of the physico-chemical data of 1 and sirodesmin A indicated that the two were analogous. In addition, 2 and sirodesmin A had identical 1H NMR,13C NMRand CD spectra. Compound 4 was previously reported to be obtained by deacetylation of sirodesmin A. Differences between 1 and 2 were derived from the presence of one acetyl group. This indicated that 1 was an acetate of 2 (= sirodesmin A). Although an acetate ofsirodesmin A has been reported12), it is the acetate of the primary hydroxy group. Considering structural components (b) and (c), the absolute structures of 1 as well as 3 and 5 were determined to be as shown in Fig. 1 . Thus 1, 3 and 5 are concluded to be new e/?z-oligothiadiketopiperazine antibiotics.
Biological Activity The inhibitory effect of 1 on the relaxation ofplasmid DNAby Topo I is shown in Fig. 3 . Compound 1 inhibited the Topo I activity in a dose-dependent manner. The inhibitory effect of3 and 5 were comparable to that of 1 (Table 4) . Sirodesmin A (2) also inhibited this enzyme, but the inhibitory effect was weaker than that of compounds 1, 3 and 5 (data not shown).
To determine whether these metabolites are specific inhibitors of Topo I, the effect of 1 on the decatenation of kDNAby topoisomerase II (Topo II) was tested. Compound 1 did not inhibit the enzyme activity even at a concentration of 500 ,mm, although m-AMSA, a specific inhibitor ofTopo II, still inhibited Topo II at a concentration of 4/zm (Fig. 4) . This indicates that the inhibitory activity of 1 is specific for Topo I. Neither 3 nor 5 affected the decatenation activity of Topo II at concentrations up to 500fiM. Each cell line was cultured with each metabolite in a 96-well plate in the presence of drug for 72 hours. The proliferation was evaluated by MTTassay. Initial cell concentrations were as follows: EL4 and P815, 2 x 104/ml; HeLa S3, WiDr, A549 and G361, 4x 104/ml; B16, 5x 104/ml.
The growth inhibitory activities of these metabolites against murine and humantumor cells are shown in Table 5 . They strongly suppressed the growth of all tumor cell lines tested.
The analysis of chromosomal DNAextracted from tumor cells treated with 1 is shown in Fig. 5 . DNAfragmentations corresponding to the nucleosomal ladders were detected in SW48and HeLa S3 cell lines. Similar results were also obtained in other cell lines at higher concentrations or with longer exposure. These results indicate that 1 induces apoptosis of tumor cells.
Antimicrobial activities of 1, 3 and 5 are shown in Table 6 . They were active against Gram-positive bacteria but showed no antimicrobial activity against Gram-negative bacteria, yeasts or fungi. 
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Minimuminhibitory concentration (MIC) was determined by the agar dilution method with antibiotic medium 3 +0.5% yeast extract, * TSA+3%glycerin or t TSA+lVo glucose.
Chemical Modification TAN-1496components are potent inhibitors of Topo I as well as proliferation of tumor cells in vitro', however, the e/?/-oligothiadiketopiperazine antibiotics are known to be highly toxic substances9). Optimal chemotherapeutic coefficient is required for improved antitumor activity. In addition, TAN-1496is very lipophilic that it is hardly dissolved in an aqueous solution, and it has very low bioavailability in vivo. Therefore, we searched for more bioavailable and less toxic derivatives by means of chemical modifications.
For these purposes, (I) introduction of a hydrophilic group and (II) reductive cleavage of the disulflde bond were examined.
Compound1 has a hydroxymethyl group, which seemed to be a key function for the first purpose. The general method for preparation of carbamate derivatives is as follows. Compound1 was treated with a-chloroethyl chloroformate (a-CECF) and pyridine in dichloromethane to afford the carbonate (7). This compound gave the monosulfide derivative (8) on treatment with triphenylphosphine. Carbonate 7 or 8 was mixed with amines bearing protected (unprotected) hydrophilic functions such as amines, carboxylic acids, alcohols to give the corresponding carbamates. In this mannerwereprepared piperazine carbamates 9 (R'=H, n=2), 10 (R'=Me, n=2) and ll (R'=H, n= l), 2-aminocyclopentane-l-carboxylic acid13) (ACPC) carbamate 12 (n = 2), 4-oxalysine14) carbamate 13 (n = 2) and D-glucosamine carbamate 14 (n = 2) as shown in Fig. 6 . These derivatives are water-soluble, and the solubilities of 9, 10 and ll (hydrochlorides) in water are more than lOmg/ml.
Compound 1 has a disulfide bridge on the diketopiperazine ring. Reduction with Raney nickel (W-2) in ethanol gave completely desulfurized compound 15. Treatment with sodium borohydride (NaBH4) in methanol cleaved the disulfide bond to give dithiol derivative 16. It was assumed that this product would be oxidized back to the disulfide in the presence of oxygen; therefore, the free thiol groups should be protected. Compound1 was S-methylated with iodomethane in pyridine and then reduced with NaBH4 in methanol to give bis(methylthio) derivative 17 in good yield. Compound 16 was monomethylated with iodomethane and pyridine in dichloromethane to afford monomethylthio derivative 18. In the 1H-1H COSYexperiment on 18, the SH proton (S 4.43 ppm, s) showed cross peaks with the C7-methylene protons (S 3.04 and 3.42ppm). Therefore, 18 was proved to have the methylthio group (S 2.18 ppm) on C3 position. When4 was heated with 1,l'-carbonyldiimidazole (CDI) in toluene, it gave cyclic carbonate 19. These results are summarizedin Fig. 7 .
Biological Activity of TAN-1496 Analogs Inhibitory effects on topoisomerases and growth of HeLa cells with 1 and the obtained derivatives (6~19) are listed in Table 7 . The monosulfides 6 and ll caused weak or no growth inhibition in spite of their inhibitory activity against Topo I. This apparent disagreement between these two activities seemed to be derived from the difference in assay methods. The incubation time needed for the enzymatic reaction ofTopo I was about 40 minutes at 37°C, while that for growth of HeLa cell was 72 hours at the same temperature. The half-life period (T1/2) of 6 was 2 hours at 37°C in a phosphate buffer (pH 7.0); therefore, 6 did not exist throughout the growth inhibition assay. This lability may be caused by strain of the bicyclo- [2, 2, 1] It is of much interest that 19 inhibited topoisomerase activity and proliferation of tumor cells without any sulfur atoms. Comparing the biological properties of 1 and 19 could be useful to investigate the significance of the disulfide bond in this family of antibiotics.
Discussion
We described here new Topo I inhibitors belonging to the <?/>/-oligothiadiketopiperazine class of fungal metabolites. These metabolites suppressed the growth of various tumor cells and induced apoptosis. This implies that the inhibitory effect of these metabolites on Topo I may play an important role in apoptotic death of tumorcells15'16).
TAN-1496A does not stabilize the Topo I-DNAreaction intermediate "cleavable complex" (data not shown), whereas CPT is known to inhibit Topo I by stabilizing it17). Moreover, this metabolite does not intercalate into DNA(data not shown). These data indicate that TAN-1496 A may inhibit Topo I itself before it binds to DNA18).These findings suggest that these metabolites would be a novel type of antitumor agent with a mode of action different from that of CPT. They are also expected to be potent tools to shed light on the function of Topo I such as transcription and recombination in eukaryotic cells, because stabilization of cleavable complex causes the fragmentation of replicating chromosomal DNAand subsequent S-phase-specific cytotoxicity1 7' 1 9).
In another study, we confirmed that gliotoxin weakly inhibited Topo I, like sirodesmin A (data not shown). This may indicate that epz-porythiadiketopiperazines commonly have property of Topo I inhibition20).
Experimental

Materials
Supercoiled pBR322 DNAand proteinase K were purchased from WAKO Pure Chemical Co., Osaka, Japan. Catenated kDNAwas purchased from TopoGENInc., Ohio, USA. Calf thymus Topo I and RNase were purchased from Takara Shuzo Co., Kyoto, Japan. Topo II was purified to homogeneity from calf thymus gland as described by Schomburg et al.21 ). Eagle's MEM,RPMI1640 medium and FBS were purchased from Whittaker M. A. Bioproducts Inc., Maryland, USA. FBS was inactivated by heating at were purchased from Sigma Chemical Co., Missouri, USA. Culture plates were purchased from Corning Laboratory Sciences Co., NewYork, USA. Antibiotic medium3 and trypticase soy agar were purchased from Difco Laboratories Co., Michigan, USAand Becton Dickinson and Co., Maryland, USA, respectively.
Relaxation Activity of Topo I Topo I activity was determined by detecting the conversion of supercoiled pBR322DNAto its relaxed form. The reaction mixture contained 50mMTris-HCl buffer (pH 8.0), 100mMKC1, 10mMMgCl2, 0.5 mM dithiothreitol (DTT), 30/xg/ml of bovine serum albumin (BSA), pBR322 DNA(0.25 /jg), 2/xl of sample solution and 1 unit of Topo I in a total volume of 20/xl. The mixture was incubated at 37°C for 40minutes The reaction was terminated by adding 4^1 of loading buffer containing 0.25% bromophenol blue, 40% glycerol and 2.5% SDS. The reaction mixture was subjected to agarose gel electrophoresis at 100Vfor 35 minutes in the presence of 0.1% SDS in 89mMTris-borate buffer (pH 8.9) containing 2mMEDTA. Gels were stained with ethidium bromide and washed thoroughly with distilled water. The DNAband was visualized over UV light and photographed with Polaroid type 667 positive/negative film. One unit of Topo I activity was defined as the amount of the enzyme that converted 0.25 fig of supercoiled pBR322 DNA to its relaxed form within 40 minutes at 37°C. NOV. 1994 Decatenation Activity of Topo II Topo II activity was determined by detecting the conversion of catenated kinetoplast DNA(kDNA) to minicircle monomers. The reaction mixture contained 50mMTris-HCl buffer (pH 8.0), 100him KC1, 10mM MgCl2, 0.1mM EDTA, 1 mM ATP, 0.5mM DTT, 30j*g/ml ofBSA, kDNA (0.2^g), 2fi\ of sample solution and 1 unit of Topo II in a total volume of 20jA. The mixture was incubated at 37°C for 20 minutes. DNAwas analyzed by agarose gel electrophoresis as described above. One unit of the Topo II activity was defined as the amount of the enzyme that decatenated 0. 2 fig ofkDNAwithin 20 minutes at 37°C. Cytotoxicity EL4murine lymphoma, P815 murine mastcytoma and SW48humancolon adenocarcinoma cell lines were purchased from the American Type Culture Collection (ATCC). B16 murine melanoma cells were a gift from Japanese Research Resources Bank. HeLa S3 human epitheloid carcinoma, WiDr human colon adenocarcinoma, A549 humanlung carcinoma and G361humanmelanomacells were obtained from the Institute for Fermentation, Osaka. All cell lines except EL4 and P8 1 5 were cultured with Eagle's minimum essential medium (Eagle's MEM)containing 10% fetal bovine serum (FBS), 5 mMglutamine and 20 /^g/ml of gentamicin. EL4 and P815 cell lines were cultured with RPMI1640 containing FBS, 5mMglutamine, 20 jug/ml of gentamicin and 0.05 mM2-mercaptoethanol. In these conditions, all the cells became con fluent within 72 hours incubation. The cells at the indicated concentration in 0.1 ml of the culture mediumwere incubated with each metabolite at 37°C for 72 hours in an atmosphere of 5% CO2in air. Growth of these cell lines was measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay22).
Detection of DNAFragmentation
One million cells in 3 ml of the culture medium were plated in a 6 well plate. After 18 hours incubation, 1 was added followed by incubation for another 18 hours. The cells were then harvested, and genomic DNAwas isolated essentially following the method of Miller et al.23\ Harvested cells were resuspended in 300^1 of nuclei lysis buffer consisting of 10mMTris-HCl (pH 8.2), 400mMNaCl and 2mMEDTA. The cell lysates were digested by incubation with 50/d of lOmg/ml proteinase K and 25^1 of 10% SDS at 37°C overnight. The reaction mixture was shaken vigorously with 100/il of saturated NaCl. After centrifugation, 350/A of supernatant was mixed with 700//I of ethanol. Precipitated DNAwas dried, dissolved in 10mMTris-HCl buffer (pH 8.0) containing 1 mMEDTAand incubated at 37°C for 1 hour in the presence of 10 units of RNase A. The purified chromosomal DNAwas analysed by agarose gel electrophoresis as described above.
Antimicrobial Activity Antimicrobial activities of 1, 3 and 5 were determined by the agar dilution method. Antibiotic medium 3 supplemented with 0.5% yeast extract was used for commonbacteria. Trypticase soy agar (TSA) supplemented with 3% glycerol was used for acid-fast bacteria and TSAsupplemented with 1 % glucose was used for yeasts and fungi. Bacteria were grown at 37°C for 18 hours, whereas yeasts and fungi were grown at 28°C for 48 hours.
General
The UVand CD (JASCO J-20 with DP-501N) spectra were measured at 23~28°C in methanol. The IR spectra were measured in KBr pellets. The EI-MS spectra were measured on a Jeol JMS-DX3O3 instrument. The^-values in the NMRspectra were recorded in ppm down field from tetramethylsilane (TMS) using a Bruker AC-300 spectrometer.
Isolation of1, 2, 3, 4 and 5 The culture filtrate (80 liters) of Microsphaeropsis sp. FL-16144 was adjusted to pH 7.0 and extracted with EtOAc (27 liters) twice. The organic layer was washed with 2% sodium bicarbonate (25 liters), 0.02 n HC1 (25 liters) and water (25 liters, twice) and concentrated. The remainder was triturated with hexane to give a powder (7.1 g). This powder was dissolved with a minimumvolume of MeOH, adsorbed on silica gel (ca. lO g) and dried in air. The crude material on silica gel was chromatographed on a column of silica gel (500 ml). Fraction-I (Fr.-I), eluted with EtOAc -hexane (1 : 2), was concentrated to give a crude powder of1 (4.4g). Fr.-II, eluted with EtOAc-hexane (2 : 1), gave a mixture of2, 3, 4 and 5 (767mg) as a yellowish powder. Fr.-III, eluted with EtOAc-hexane (3 : 1), afforded a mixture of 1, 2, 3 and 5 (214mg) as a pale yellow powder. The powders from Fr.-I and Fr.-II were independently re-chromatographed on silica gel (300 and 80ml) eluting with MeOH-CHCl3. Fr.-I gave powders of pure 1 and a mixture of 1, 2 and 3 (561 mg). The former was crystallized from Et2O to afford 1 (1.71 g) as fine crystals. Fr.-II gave powders of crude 3 (286mg), pure 4 (60mg) and a mixture of 2, 3 and 5 (379mg). The crude powder of 3 was re-chromatographed on silica gel (30 ml) eluting with EtOAc -hexane to give a crude powder of 3 (221 mg acetonitrile-0.01 m phosphate buffer (pH 6.3) to afford 1 (251 mg) and 2 (345mg) and a mixture of3 and 5 (129mg) as pale yellow powders. This mixture was chromatographed on silica gel (20ml) eluting with EtOAc -hexane to give powders of5 (44mg) and crude 3 (79 mg). The latter and the crude powder (201 mg) of3 from Fr.-II were mixed and subjected to prep. HPLCwith a mobile phase of 40%acetonitrile-0.01 m phosphate buffer (pH 6.3) to give a crude powder of 3 (49 mg). This was again chromatographed on silica gel (10ml) eluting with EtOAc-toluene to give 3 (14mg) as a white powder.
Mono-desulfurization of 1 (6) A solution of 1 (195mg, 0.369mmol) in THF (6.5ml) was stirred with triphenylphosphine (100mg, 1.0eq) at ambient temperature for 15 hours. The reaction mixture was diluted with EtOAc (7ml) and hexane (3 ml) and washed with water (5 ml). The aqueous layer was mixed with a mixture of EtOAc and hexane (2: 1, 6ml). The organic layers were combined and washed with water and brine (10ml), dried over anhydrous sodium sulfate and concentrated to give an oil (309mg). This oil was applied to a silica gel column (Merck, Silica gel 60, Art. 7734, lOg) and eluted with a mixed solvent of EtOAc and hexane to give 6 (148mg, 0.299mmol, 81%) as a white powder. a-Chloroethylcarbonation of 1 (7) A solution of 1 (990mg, 1.87mmol) in dichloromethane (33ml) was stirred with pyridine (0.23ml, 1.5 eq) and a-CECF (43% in dichloromethane solution, 0.56ml, 1.2eq) at 0°C for 30 minutes. Additional pyridine (0.23 ml) and a-CECF (0.17 ml, 0.3 eq) were added to the mixture, and 2.5 hours later, the reaction mixture was mixed with 5%ammoniumchloride (50 ml). The aqueous layer was extracted with a mixture of EtOAc and hexane (1 : 2, 60 ml) twice. The organic layers were combined, washed with 0.05 n HC1 twice, 2%sodium bicarbonate, water and brine (50ml, each), dried over anhydrous sodium sulfate and concentrated to give a powder (1.31 g). This was applied to a silica gel column (Merck, Silica gel 60, Art. 7734, 40g) and eluted with a mixed solvent ofEtOAc and hexane (1 :2~2: 3) to give 7 (1.15g, 1.81 mmol, 97%) as a white powder. a-Chloroethylcarbonation of 6 (8) A solution of 6 (381 mg, 0.768 mmol) in dichloromethane (12ml) was stirred with pyridine (0.12ml, 2.0 eq) and a-CECF (43% in dichloromethane solution, 0.23 ml, 1.2eq) at 0°C for 90 minutes. Additional pyridine (0.06ml) and a-CECF (0.04ml, 0.2eq) were added to the mixture. One hour later, the reaction NOV. 1994 mixture was diluted with a mixture of EtOAc and hexane (1 : 1, 30ml) . The mixture was washed with 0.05n HC1 twice, 2% sodium bicarbonate, water and brine (15ml, each), dried over anhydrous sodium sulfate and concentrated to give a powder (467 mg). This was applied to a silica gel column (Merck, Silica gel 60, Art. 7734, 20g) and eluted with a mixed solvent ofEtOAc and hexane (1 : 2~2 : 3) Piperazine Carbamate of 1 (9) A solution of 7 (176mg, 0.277mmol) in dichloromethane (6.0ml) was stirred with triethylamine (0.15ml, 4eq) and piperazine (49mg, 2eq) at 0°C for 60 minutes. The reaction mixture was mixed with EtOAc (8ml), hexane (8ml) and 0.16n HC1 (10ml). The aqueous layer was washed with a mixture of EtOAc and hexane (1 : 1, 10ml), adjusted to pH 8.4 and extracted with EtOAc (10ml) three times. The EtOAc layers were combined, washed with 2%sodium bicarbonate, water and brine (15 ml, each), dried over anhydrous sodium sulfate and concentrated to give a powder of9 (171 mg). This powderwas dissolved in 0. 1 n HC1 (2.6 ml) and freeze-dried to give 9 hydrochloride (159 mg, 0.235 mmol, 85%) as awhitepowder. IR : 3440, 2970, 2940, 1750, 1700, 1430, 1370, 1240, 1170, 1080, 1050 (cm"1) 7V-Methylpiperazine Carbamate of 1 (10) A solution of 7 (156mg, 0.246mmol) in dichloromethane (5.0ml) was stirred with triethylamine (0.17ml, 5 eq) and TV-methylpiperazine (0.05ml, 2 eq) at 0°C for 90 minutes. The reaction mixture was mixed with EtOAc (5 ml), hexane (5 ml) and 0.18 n HC1 (10ml). The organic layer was extracted with 10% ammonium chloride (6ml). The aqueous layers were combined, washedwith a mixture of EtOAcand hexane (1 : 1, 6ml) , adjusted to pH 8.4 and extracted with EtOAc (10ml) three times. The EtOAc layers were combined, washed with 2%sodium bicarbonate, water and brine (10 ml, each), dried over anhydrous sodium sulfate and concentrated to give a powder of 10 (161 mg, quant.). This powder (60 mg) was dissolved in 0.1 n HC1 (0.8ml) and freeze-dried to give 10 hydrochloride (57mg) as a white powder.
Anal Calcd for C28H39N4O10S2Cl- 1.5H2O: C 46.82, H 5.89, N 7.80, S 8.93, Cl 4.94. Found: C 46.94, H 5.79, N 7.79, S 8.70, Cl 4.79. IR: 3440, 2970 , 2940 , 1750 , 1700 , 1460 , 1430 , 1370 , 1240 , 1180 , 1110 , 1080 , 1050 Piperazine Carbamate of 8 (ll) A solution of8 (676 mg, 1.12 mmol) in dichloromethane (22 ml) was stirred with triethylamine (0.31 ml, 2 eq) and piperazine (197mg, 2eq) at 0°C for 90 minutes. The reaction mixture was mixed with hexane (40ml) and 0.2n HC1 (17ml). The organic layer was extracted with water (15ml). The aqueous layers were combined, washed with a mixture ofEtOAc and hexane (1 : 2, 30 ml), adjusted to pH 8.4 and extracted with EtOAc (30ml) three times. The EtOAc layers were combined, washed with water and brine (30ml, each), dried over anhydrous sodium sulfate and concentrated to give a powder of ll (561 mg). This powder was dissolved in 0.1 n HC1 (9.0ml) and freeze-dried to give ll hydrochloride (551 mg, 0.854mmol, 76%) as a white powder. Anal Calcd for C27H37N4O10SC1 2H2O: C 47.61, H 6.07, N 8.23, S 4.71, Cl 5.20. Found: C 47.46, H 5.97, N 8.06, S 4.37, Cl 6.18. IR: 3440, 2970 , 2940 , 1720 , 1630 , 1440 , 1370 , 1250 , 1160 , 1110 , 1080 , 1040 13C 4-Oxalysine Carbamate of 1 (13) A solution of7 (130mg, 0.20mmol) and 4-oxalysine tert-butyl ester di-acetic acid salt (69mg, 1.05 eq) in DMF(4.0ml) was stirred with triethylamine (0.09ml, 3eq) at room temperature for 3.5 hours. The reaction mixture was evaporated, mixed with 0.02n HC1(15ml) and washed with a mixture of EtOAc and hexane (1 : 2, 15ml) twice. The organic layers were combined and extracted with 0.02n HC1 (10ml) twice. The aqueous layers were combined, adjusted to pH 8.5 and extracted with EtOAc (12ml) three times. The EtOAclayers were combined, washed with 2% sodium bicarbonate, water and brine (15ml, each), dried over anhydrous sodium sulfate and concentrated to give a powder (128mg). This (114mg) was mixed with TFA(0.5 ml) at ambient temperature for 30 minutes. The reaction mixture was evaporated and diluted with Et2O to give a powder. This powder (75 mg) was subjected to preparative HPLC(column, ODS; YMC-pack D-ODS-5, mobile phase, 30% acetonitrile/0.01 m P. B.; pH 6.3). The fractions eluted with 310 -350 ml of the solvent were concentrated, desalted with Microacilizer Gl and lyophilized to give a white powder (22mg). This powder (ll mg) was desalted with Diaion HP-20 (Mitsubishi Chemical Industries Ltd.) chromatography eluting with aqueous MeOH.The fraction eluted with 80% MeOHwas concentrated and lyophilized to give 13 (6mg, 8.5/miol, 5.7%) as a white powder. D-Glucosamine Carbamate of 1 (14) A solution of 7 (389mg, 0.613mmol) and D-glucosamine acetic acid salt (203mg, 1.5eq) in DMF (8.0ml) was stirred with triethylamine (0.15ml, 2eq) at 0°C for 5 hours and then with DMAP(8mg) for S-Methylation of 16 (18) A solution of 16 (94mg, 0.177mmol) in dichloromethane (3ml) was stirred with pyridine (0.14ml, lO eq) and iodomethane (0.05 ml, 4eq) at room temperature for 5 hours. The reaction mixture was diluted with EtOAc (20ml) and Et2O (4ml), washed with 0.02n HC1, 2% sodium bicarbonate, water and brine (10 ml, each), dried over anhydrous sodium sulfate and concentrated to give a powder (58 mg). This powder was subjected to silica gel thin layer chromatography (Merck, Silica gel 60, Art. 5717, 200 x 150mm) developing with EtOAc. The band of Rf 0.4-0.6 was separated and eluted with 10% methanol -EtOAc. The eluate was evaporated to give 18 (ll mg, 0.02mmol, 11%) as a white powder. 
Cyclic Carbonation of 4 (19).
A solution of 4 (HOmg, purity 83%, 0.205mmol) in toluene (5.5ml) was stirred with lj'-carbonyldiimidazole (170 mg, 5 eq.) at 80°C for 4 hours. The reaction mixture was filtered. The filtrate was diluted with EtOAc (10 ml) and hexane (5 ml), washed with 10% ammonium chloride, water and brine (10ml, each), dried over anhydrous sodium sulfate and concentrated to give a powder (147mg). This powder was subjected to silica gel thin layer chromatography (Merck, Silica gel 60, Art. 5717, 200 x 200 mm) developing with a mixture of EtOAc-hexane (2 : 1). The band of Rf 0.53~0.66 was separated and eluted with EtOAc. The eluate was evaporated to give 19 (45mg, 0.116mmol, 57%) as a white powder.
Anal Calcd for C19H20N2O7- 1.5H2O: C 54.94, H 5.58, N 6.74. Found: C 55.02, H 5.21, N 6.54. IR: 3450, 2980 , 1820 , 1760 , 1690 , 1640 , 1610 , 1430 , 1350 , 1230 , 1170 
